CION Ameerpet
Diagnosis · Reviewed by CION Oncologists · NABH Accredited
The CA-125 Blood Test — What It Does and Does Not Tell You
If you are reading this at night with a report in front of you showing a raised CA-125, start here: this is not a cancer test. It cannot diagnose endometrial cancer and it cannot rule it out. Many women with endometrial cancer have an entirely normal CA-125, and a great many women with a raised CA-125 have no cancer at all — endometriosis, fibroids, a cyst, an infection, even a recent operation will raise it. The number on its own means very little. What follows explains what the test actually measures, why it goes up, and the narrow circumstances in which it is genuinely useful in endometrial cancer.
- Not a screening or diagnostic test — for this disease it cannot rule in or out
- Many benign causes — endometriosis, fibroids, infection, surgery
- Normal results occur with cancer present — so a normal value proves nothing either
- Useful mainly as a baseline and trend — in specific situations, not routinely
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Why CA-125 Goes Up
A long list, and cancer is one entry on it. Where you sit on this list depends far more on your symptoms and your scan than on the number itself.
| Cause | How it relates to the result |
|---|---|
| Endometriosis | A very common cause of a raised CA-125 in women before menopause, and it can push the level up considerably. Entirely benign, and a frequent source of alarm when the result is read without that context. |
| Fibroids and adenomyosis | Both commonly raise the level, both extremely common in the age group being tested, and both benign. See pelvic pain. |
| Ovarian cysts and pelvic infection | A cyst that has bled or ruptured, or pelvic inflammatory disease, will raise it. The level typically settles once the problem resolves, which is why repeating the test later is often more informative than acting on one value. |
| Menstruation and pregnancy | Both raise CA-125 in perfectly healthy women. Timing of the sample relative to the cycle genuinely matters and is often not taken into account. |
| Recent abdominal or pelvic surgery | Any operation irritates the lining of the abdomen and pushes the level up for a period afterwards. A result taken soon after surgery should be read with that firmly in mind. |
| Liver disease and heart failure | Both cause fluid to accumulate in the abdomen, which raises CA-125 substantially. Nothing to do with cancer at all, and a common explanation in older patients. |
| Tuberculosis and other infections | Peritoneal tuberculosis raises CA-125 markedly and can mimic advanced ovarian cancer on scans as well. A genuinely important consideration in India, and one where jumping to a cancer diagnosis has real consequences. |
| Cancer | Ovarian cancer most characteristically; also endometrial, and several others. In endometrial cancer, elevation is commoner where disease is more advanced or of a higher-risk type, and is frequently absent in early disease. |
Do not compare your number against a threshold you found online. Assays and reference ranges vary between laboratories, and a value must be read against the range printed on your own report and in the context of your symptoms, your examination and your scan. A number alone, without that context, is not information — it is anxiety.
Did You Know? CA-125 is produced by tissues lining the abdominal cavity, and it rises whenever those tissues are irritated — by a cancer, certainly, but equally by endometriosis, a burst cyst, an infection, recent surgery, liver disease or heart failure. It is not a cancer-specific protein and it was never designed to be one. Its established role is in ovarian cancer, where it is used alongside imaging in assessing an ovarian mass and in monitoring known disease. In endometrial cancer it plays a much smaller part, and it has no role at all in deciding whether a woman with abnormal bleeding needs investigation. That decision is made on the bleeding itself, on a scan, and on a biopsy. Sources: NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; RCOG guidance on the investigation of postmenopausal bleeding.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Where It Is Genuinely Useful
Narrow, specific, and worth knowing so that you can tell whether it applies to you.
- As a baseline in higher-risk or advanced disease. If the level is elevated at diagnosis, it becomes a measurable thing that can be tracked. If it is normal at diagnosis, it will not be useful for tracking later — which is itself worth knowing.
- As one component of follow-up, for some women. Where the level was raised at diagnosis and fell with treatment, a subsequent rise can prompt earlier imaging. It is used alongside symptoms and examination, never alone. See follow-up schedule.
- In assessing an ovarian mass. Its established role. Where a scan shows an ovarian abnormality, CA-125 forms part of the assessment of how likely that is to be malignant. See endometrial vs ovarian cancer.
- In higher-risk histological subtypes. Serous carcinoma and carcinosarcoma more often produce elevation, so the test has more to offer there than in low-grade endometrioid disease.
- Occasionally in planning surgery. A markedly raised level in a woman with endometrial cancer may raise the suspicion of disease beyond the uterus and prompt further imaging before an operation is planned.
What it is never used for: deciding whether a woman with abnormal bleeding needs investigating, or screening healthy women for endometrial cancer. Neither is supported. See screening.
Want Your Result Read in Context?
A raised CA-125 means little on its own. Examination and ultrasound in the same visit give it meaning.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A Number Without Context Is Not Information
Your symptoms, your examination and your scan are what give a CA-125 result any meaning at all.
What to Do About a Raised Result
A practical sequence rather than a reason to panic.
Do not act on it in isolation
The result means almost nothing without an examination and a pelvic scan. It is not a diagnosis and it is not a reason to conclude anything. If it was taken as part of a general health package with no symptoms at all, that context alone makes a benign explanation much the most likely.
Ask why it was ordered
A genuinely useful question. If it was ordered to assess an ovarian mass, it has a defined role. If it was ordered because you have abnormal bleeding, it will not answer that question — bleeding is investigated by ultrasound and biopsy, not by a blood test. If it came in a routine package, it was not answering a question at all.
Have the pelvic scan done
This is the test that actually informs the situation — it looks at the uterus, the lining and the ovaries and provides the context in which the number means something. See transvaginal ultrasound.
Consider repeating it later
Where the elevation is mild and the scan is reassuring, repeating the test after an interval is often more informative than any single value. Levels that rise from a benign cause typically settle; a trend tells you more than a point.
Report symptoms, whatever the number
A normal CA-125 does not exclude anything. If you have abnormal bleeding — and above all any bleeding after menopause — that needs assessment regardless of what the blood test showed. Do not let a normal result delay it. See bleeding after menopause.
Raised CA-125 and Nobody Has Explained It?
Bring your report and any scans. A proper explanation of what it does and does not mean. The opinion is free.
CA-125 During Follow-Up
If you are being followed up after treatment, a few things worth understanding.
- It is only useful if it was raised to begin with. Where your level was normal at diagnosis, tracking it afterwards adds little, because a cancer that did not produce it then is unlikely to announce a recurrence through it now. Ask whether yours was elevated at the start.
- A single rise is not a recurrence. It prompts a closer look — repeating the test, examination, and imaging where indicated. Levels fluctuate, and a rise from a benign cause such as an infection is common.
- Symptoms matter more than the number. Vaginal bleeding after treatment, new pelvic pain, or a persistent change in bowel or bladder habit should be reported when they arise, whatever the blood test showed. See recurrence.
- Not everyone needs it in follow-up. Routine tumour marker testing after treatment for early endometrial cancer is not standard practice, because it has not been shown to improve outcomes and it generates a good deal of anxiety. If you are not having it, that is not neglect.
- Ask who reviews the result and when. A blood test that nobody has agreed to look at is worse than no blood test. Establish who sees it and how you will be told.
Why a Number Needs a Consultation
A raised marker with no context generates more fear than almost any other result we are shown.
45-minute consultations
One place for the whole pathway
Slides reviewed, not just the summary line
Tumour board for every diagnosis
Named MCh surgical oncologists
Costs explained before you commit
Take The Next Step
Ask Why the Test Was Ordered
If it came in a health package with no symptoms, that alone makes a benign explanation much the most likely.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
CA-125 — Frequently Asked Questions
Does a raised CA-125 mean I have endometrial cancer?
No. CA-125 is not a diagnostic test for endometrial cancer and cannot establish or exclude it. It is a protein released when the tissues lining the abdominal cavity are irritated, which happens in cancer but equally in endometriosis, fibroids, adenomyosis, ovarian cysts, pelvic infection, liver disease, heart failure, recent surgery, tuberculosis, and even during menstruation or pregnancy. A mild elevation in a woman without symptoms is far more likely to reflect one of these than a cancer. What gives the number meaning is your symptoms, an examination and a pelvic ultrasound — not the value on its own.
Can I have endometrial cancer with a normal CA-125?
Yes, and this is important. Many endometrial cancers — particularly early-stage, low-grade disease confined to the uterus — occur with an entirely normal CA-125. The test lacks the sensitivity to be used for exclusion. This means a normal result must never delay the assessment of abnormal bleeding. If you have bleeding after menopause, or abnormal bleeding before it, that needs an ultrasound and usually a biopsy of the uterine lining regardless of what any blood test showed. Reassurance from a normal marker in the presence of a symptom is false reassurance.
Should CA-125 be used to screen for endometrial cancer?
No, and it is not recommended for that purpose by any guideline. It lacks both the sensitivity and the specificity required: it misses many cancers and it is raised in a great many women who do not have one. Screening healthy women with it would generate large numbers of false alarms, each leading to further tests and considerable anxiety, while providing little useful detection. There is no screening programme for endometrial cancer in women at ordinary risk anywhere in the world. What works is responding promptly to symptoms, particularly any bleeding after menopause.
My level is slightly above the range on my report. How worried should I be?
Mild elevation is common and usually benign, and the sensible response is assessment rather than alarm. Ask why the test was ordered — if it came as part of a routine health package with no symptoms at all, a benign explanation is much the most likely. The useful next step is an examination and a pelvic ultrasound, which look at the uterus, the lining and the ovaries and provide the context the number lacks. Where the elevation is mild and the scan reassuring, repeating the test after an interval is often more informative than any single value, since levels raised by benign causes typically settle.
Will I need CA-125 tests during follow-up?
Not necessarily. Routine tumour marker testing after treatment for early endometrial cancer is not standard practice, because it has not been shown to improve outcomes and it generates considerable anxiety. Where it is used, it is generally in women whose level was elevated at diagnosis and fell with treatment, since a subsequent rise can then prompt earlier imaging. If your level was normal to begin with, tracking it afterwards adds little. In every case it is one input alongside symptoms and examination, never a test read alone — and any vaginal bleeding, new pelvic pain or persistent change after treatment should be reported whatever the number shows.
Medical disclaimer: This page provides general information about the CA-125 blood test, reviewed by a CION oncologist. It is not a substitute for individual medical advice. CA-125 cannot diagnose or exclude endometrial cancer. Reference ranges and assay methods vary between laboratories, so results should be interpreted against your own report and by the clinician who knows your clinical context. Any abnormal or postmenopausal bleeding should be assessed regardless of the result of any blood test.